Colon Targeted Liposomal Systems (CTLS): Theranostic Potential

Area of Science:

• Nanotechnology and Pharmaceutical Sciences
• Drug Delivery Systems
• Colonic Therapeutics and Diagnostics

Background:

• Colon targeted liposomal systems (CTLS) are emerging as a significant area of research for treating colonic ailments.
• While liposomes are traditionally not considered ideal for oral colon targeting, recent advancements are changing this perspective.
• This review focuses on the innovative applications and potential of CTLS.

Purpose of the Study:

• To review the latest advancements in colon targeted liposomal systems (CTLS).
• To explore the use of various ligands for enhancing CTLS efficacy.
• To highlight the theranostic (therapeutic and diagnostic) capabilities of CTLS.

Main Methods:

• Review of existing literature on colon targeted liposomal systems.
• Analysis of various targeting ligands employed in CTLS, including peptides, proteins, Sialyl Lewis X (SLX), folate, antibodies, and sulfatide.
• Investigation of diagnostic applications using radiolabeled CTLS for imaging.

Main Results:

• CTLS can be effectively designed using diverse ligands like RGD peptides, NGR peptides, fibronectin mimetic peptide, transferrin, SLX, folate, monoclonal antibodies, endostatin gene, and sulfatide for targeted delivery.
• The diagnostic potential of CTLS is demonstrated through the use of radioisotopes such as (188)Re, (99m)Tc, and (111)In for imaging purposes.
• Nanotechnology-based approaches are crucial for the development of advanced CTLS.

Conclusions:

• Colon targeted liposomal systems offer promising avenues for both therapeutic interventions and diagnostic imaging of colonic diseases.
• The strategic incorporation of specific ligands significantly enhances the targeting efficiency of liposomes to the colon.
• CTLS represent a significant advancement in theranostic exploration for colonic ailments, benefiting researchers in liposome design and development.